Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MIXL1
|
ENSG00000185155.7 | Mix paired-like homeobox |
GSX1
|
ENSG00000169840.4 | GS homeobox 1 |
BSX
|
ENSG00000188909.4 | brain specific homeobox |
MEOX2
|
ENSG00000106511.5 | mesenchyme homeobox 2 |
LHX4
|
ENSG00000121454.4 | LIM homeobox 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
LHX4 | hg19_v2_chr1_+_180199393_180199426 | 0.39 | 3.3e-02 | Click! |
MEOX2 | hg19_v2_chr7_-_15726296_15726437 | 0.15 | 4.1e-01 | Click! |
MIXL1 | hg19_v2_chr1_+_226411319_226411366 | 0.02 | 9.1e-01 | Click! |
GSX1 | hg19_v2_chr13_+_28366780_28366780 | -0.02 | 9.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_152386732 | 5.99 |
ENST00000271835.3
|
CRNN
|
cornulin |
chr4_+_69313145 | 3.75 |
ENST00000305363.4
|
TMPRSS11E
|
transmembrane protease, serine 11E |
chr4_-_69111401 | 2.17 |
ENST00000332644.5
|
TMPRSS11B
|
transmembrane protease, serine 11B |
chr10_+_17270214 | 2.09 |
ENST00000544301.1
|
VIM
|
vimentin |
chr17_-_38859996 | 2.04 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
chr1_+_62439037 | 1.81 |
ENST00000545929.1
|
INADL
|
InaD-like (Drosophila) |
chr12_+_107712173 | 1.62 |
ENST00000280758.5
ENST00000420571.2 |
BTBD11
|
BTB (POZ) domain containing 11 |
chr16_-_30122717 | 1.58 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr11_+_33061543 | 1.45 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
chr11_-_121986923 | 1.39 |
ENST00000560104.1
|
BLID
|
BH3-like motif containing, cell death inducer |
chr2_+_158114051 | 1.39 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr18_+_29027696 | 1.30 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
chr9_+_12693336 | 1.25 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
chr17_-_39150385 | 1.21 |
ENST00000391586.1
|
KRTAP3-3
|
keratin associated protein 3-3 |
chr2_-_216003127 | 1.19 |
ENST00000412081.1
ENST00000272895.7 |
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr12_-_30887948 | 1.18 |
ENST00000433722.2
|
CAPRIN2
|
caprin family member 2 |
chr6_-_66417107 | 1.17 |
ENST00000370621.3
ENST00000370618.3 ENST00000503581.1 ENST00000393380.2 |
EYS
|
eyes shut homolog (Drosophila) |
chr1_-_47407097 | 1.16 |
ENST00000457840.2
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
chr2_-_208031943 | 1.15 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr12_-_10978957 | 1.13 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr7_-_28220354 | 1.13 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
chrX_-_18690210 | 1.13 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
chr12_-_25055177 | 1.03 |
ENST00000538118.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
chr17_-_57229155 | 1.02 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
chr4_+_169418255 | 1.01 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr2_-_158300556 | 0.99 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
chr4_+_40198527 | 0.98 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr12_+_82347498 | 0.96 |
ENST00000550506.1
|
RP11-362A1.1
|
RP11-362A1.1 |
chr19_-_36001113 | 0.95 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr3_-_108248169 | 0.95 |
ENST00000273353.3
|
MYH15
|
myosin, heavy chain 15 |
chr7_+_77428066 | 0.94 |
ENST00000422959.2
ENST00000307305.8 ENST00000424760.1 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr3_-_33686925 | 0.93 |
ENST00000485378.2
ENST00000313350.6 ENST00000487200.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr2_-_40680578 | 0.93 |
ENST00000455476.1
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr12_-_89746173 | 0.89 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
chr19_-_51522955 | 0.86 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr17_-_64225508 | 0.86 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr6_+_47666275 | 0.84 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr11_+_55578854 | 0.84 |
ENST00000333973.2
|
OR5L1
|
olfactory receptor, family 5, subfamily L, member 1 |
chr5_+_31193847 | 0.84 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
chr6_+_34204642 | 0.83 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr5_-_39219641 | 0.83 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
chr3_+_121774202 | 0.82 |
ENST00000469710.1
ENST00000493101.1 ENST00000330540.2 ENST00000264468.5 |
CD86
|
CD86 molecule |
chr14_+_32798547 | 0.82 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr7_+_77428149 | 0.82 |
ENST00000415251.2
ENST00000275575.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr6_-_32157947 | 0.82 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr1_-_152131703 | 0.79 |
ENST00000316073.3
|
RPTN
|
repetin |
chr3_+_186353756 | 0.77 |
ENST00000431018.1
ENST00000450521.1 ENST00000539949.1 |
FETUB
|
fetuin B |
chr9_-_123639304 | 0.77 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
chr21_-_31864275 | 0.76 |
ENST00000334063.4
|
KRTAP19-3
|
keratin associated protein 19-3 |
chr11_-_111794446 | 0.76 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr14_+_32798462 | 0.75 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr9_-_95166884 | 0.75 |
ENST00000375561.5
|
OGN
|
osteoglycin |
chr12_+_81110684 | 0.74 |
ENST00000228644.3
|
MYF5
|
myogenic factor 5 |
chr1_+_84630645 | 0.73 |
ENST00000394839.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr11_-_107729887 | 0.72 |
ENST00000525815.1
|
SLC35F2
|
solute carrier family 35, member F2 |
chr19_-_51523412 | 0.72 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
chr3_-_149095652 | 0.70 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr2_-_166930131 | 0.70 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr11_-_55703876 | 0.69 |
ENST00000301532.3
|
OR5I1
|
olfactory receptor, family 5, subfamily I, member 1 |
chr17_-_39254391 | 0.67 |
ENST00000333822.4
|
KRTAP4-8
|
keratin associated protein 4-8 |
chr6_+_151646800 | 0.67 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr4_-_143227088 | 0.66 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr9_-_95166841 | 0.66 |
ENST00000262551.4
|
OGN
|
osteoglycin |
chr1_+_84609944 | 0.66 |
ENST00000370685.3
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr2_+_68961934 | 0.66 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr12_-_48164812 | 0.65 |
ENST00000549151.1
ENST00000548919.1 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr3_+_148447887 | 0.65 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
chr2_-_214016314 | 0.65 |
ENST00000434687.1
ENST00000374319.4 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr10_+_118187379 | 0.65 |
ENST00000369230.3
|
PNLIPRP3
|
pancreatic lipase-related protein 3 |
chr10_+_32873190 | 0.65 |
ENST00000375025.4
|
C10orf68
|
Homo sapiens coiled-coil domain containing 7 (CCDC7), transcript variant 5, mRNA. |
chr8_+_22424551 | 0.64 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr2_+_210444142 | 0.63 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
chr4_-_57524061 | 0.63 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
chr12_+_26348246 | 0.63 |
ENST00000422622.2
|
SSPN
|
sarcospan |
chr4_-_57547454 | 0.63 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
chr2_+_68961905 | 0.62 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr4_-_57547870 | 0.62 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
chr19_-_51523275 | 0.62 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr17_-_39211463 | 0.62 |
ENST00000542910.1
ENST00000398477.1 |
KRTAP2-2
|
keratin associated protein 2-2 |
chr13_-_36050819 | 0.61 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr17_-_39306054 | 0.61 |
ENST00000343246.4
|
KRTAP4-5
|
keratin associated protein 4-5 |
chr12_-_91398796 | 0.61 |
ENST00000261172.3
ENST00000551767.1 |
EPYC
|
epiphycan |
chr7_-_87342564 | 0.60 |
ENST00000265724.3
ENST00000416177.1 |
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr1_-_28384598 | 0.60 |
ENST00000373864.1
|
EYA3
|
eyes absent homolog 3 (Drosophila) |
chr2_-_70780770 | 0.60 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
chr4_+_66536248 | 0.60 |
ENST00000514260.1
ENST00000507117.1 |
RP11-807H7.1
|
RP11-807H7.1 |
chr1_-_205391178 | 0.58 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr7_-_107443652 | 0.58 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
chr11_-_124190184 | 0.58 |
ENST00000357438.2
|
OR8D2
|
olfactory receptor, family 8, subfamily D, member 2 |
chr4_+_144354644 | 0.58 |
ENST00000512843.1
|
GAB1
|
GRB2-associated binding protein 1 |
chr9_-_123639445 | 0.58 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
chr1_+_152974218 | 0.58 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
chr9_+_125133315 | 0.56 |
ENST00000223423.4
ENST00000362012.2 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr17_-_39274606 | 0.55 |
ENST00000391413.2
|
KRTAP4-11
|
keratin associated protein 4-11 |
chr17_-_39203519 | 0.55 |
ENST00000542137.1
ENST00000391419.3 |
KRTAP2-1
|
keratin associated protein 2-1 |
chr14_-_64194745 | 0.55 |
ENST00000247225.6
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1 |
chr4_-_39979576 | 0.55 |
ENST00000303538.8
ENST00000503396.1 |
PDS5A
|
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
chr4_-_76928641 | 0.54 |
ENST00000264888.5
|
CXCL9
|
chemokine (C-X-C motif) ligand 9 |
chr11_-_7818520 | 0.54 |
ENST00000329434.2
|
OR5P2
|
olfactory receptor, family 5, subfamily P, member 2 |
chr10_-_14372870 | 0.53 |
ENST00000357447.2
|
FRMD4A
|
FERM domain containing 4A |
chr3_+_111393501 | 0.53 |
ENST00000393934.3
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
chr7_+_129984630 | 0.53 |
ENST00000355388.3
ENST00000497503.1 ENST00000463587.1 ENST00000461828.1 ENST00000494311.1 ENST00000466363.2 ENST00000485477.1 ENST00000431780.2 ENST00000474905.1 |
CPA5
|
carboxypeptidase A5 |
chr14_-_81425828 | 0.53 |
ENST00000555529.1
ENST00000556042.1 ENST00000556981.1 |
CEP128
|
centrosomal protein 128kDa |
chr5_-_147162078 | 0.53 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr6_-_31107127 | 0.52 |
ENST00000259845.4
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr12_+_122688090 | 0.52 |
ENST00000324189.4
ENST00000546192.1 |
B3GNT4
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 |
chr16_+_24741013 | 0.52 |
ENST00000315183.7
ENST00000395799.3 |
TNRC6A
|
trinucleotide repeat containing 6A |
chr4_-_20985632 | 0.51 |
ENST00000359001.5
|
KCNIP4
|
Kv channel interacting protein 4 |
chr4_-_89951028 | 0.51 |
ENST00000506913.1
|
FAM13A
|
family with sequence similarity 13, member A |
chr12_+_4385230 | 0.51 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
chr8_-_49833978 | 0.51 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
chr21_-_42219065 | 0.51 |
ENST00000400454.1
|
DSCAM
|
Down syndrome cell adhesion molecule |
chr2_-_55647057 | 0.51 |
ENST00000436346.1
|
CCDC88A
|
coiled-coil domain containing 88A |
chr1_-_67266939 | 0.51 |
ENST00000304526.2
|
INSL5
|
insulin-like 5 |
chr17_-_9694614 | 0.50 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
chr4_+_70796784 | 0.50 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
chr14_+_67291158 | 0.50 |
ENST00000555456.1
|
GPHN
|
gephyrin |
chr16_+_57279004 | 0.50 |
ENST00000219204.3
|
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein |
chr17_+_17082842 | 0.50 |
ENST00000579361.1
|
MPRIP
|
myosin phosphatase Rho interacting protein |
chr16_-_20364030 | 0.49 |
ENST00000396134.2
ENST00000573567.1 ENST00000570757.1 ENST00000424589.1 ENST00000302509.4 ENST00000571174.1 ENST00000576688.1 |
UMOD
|
uromodulin |
chr15_-_64673630 | 0.49 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
chr2_+_169926047 | 0.49 |
ENST00000428522.1
ENST00000450153.1 ENST00000421653.1 |
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
chr15_+_75080883 | 0.49 |
ENST00000567571.1
|
CSK
|
c-src tyrosine kinase |
chr4_-_109541539 | 0.49 |
ENST00000509984.1
ENST00000507248.1 ENST00000506795.1 |
RPL34-AS1
|
RPL34 antisense RNA 1 (head to head) |
chr17_+_42785976 | 0.48 |
ENST00000393547.2
ENST00000398338.3 |
DBF4B
|
DBF4 homolog B (S. cerevisiae) |
chr1_-_232598163 | 0.48 |
ENST00000308942.4
|
SIPA1L2
|
signal-induced proliferation-associated 1 like 2 |
chr6_-_109777128 | 0.48 |
ENST00000358807.3
ENST00000358577.3 |
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr9_-_123639600 | 0.48 |
ENST00000373896.3
|
PHF19
|
PHD finger protein 19 |
chr14_-_72458326 | 0.48 |
ENST00000542853.1
|
AC005477.1
|
AC005477.1 |
chr5_+_115177178 | 0.48 |
ENST00000316788.7
|
AP3S1
|
adaptor-related protein complex 3, sigma 1 subunit |
chr2_-_68052694 | 0.48 |
ENST00000457448.1
|
AC010987.6
|
AC010987.6 |
chr1_-_24469602 | 0.47 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr8_-_101661887 | 0.47 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
chr1_+_154401791 | 0.46 |
ENST00000476006.1
|
IL6R
|
interleukin 6 receptor |
chr20_+_30697298 | 0.46 |
ENST00000398022.2
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
chr1_+_40713573 | 0.45 |
ENST00000372766.3
|
TMCO2
|
transmembrane and coiled-coil domains 2 |
chr3_+_98482175 | 0.45 |
ENST00000485391.1
ENST00000492254.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr4_-_138453606 | 0.44 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
chr18_+_61554932 | 0.44 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chrX_+_99839799 | 0.44 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
chr12_+_18414446 | 0.44 |
ENST00000433979.1
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
chr11_-_82708519 | 0.43 |
ENST00000534301.1
|
RAB30
|
RAB30, member RAS oncogene family |
chr15_+_63188009 | 0.43 |
ENST00000557900.1
|
RP11-1069G10.2
|
RP11-1069G10.2 |
chr13_+_32313658 | 0.43 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
chr10_+_69865866 | 0.43 |
ENST00000354393.2
|
MYPN
|
myopalladin |
chr1_+_152881014 | 0.42 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr8_+_7738726 | 0.42 |
ENST00000314357.3
|
DEFB103A
|
defensin, beta 103A |
chr19_+_7030589 | 0.41 |
ENST00000329753.5
|
MBD3L5
|
methyl-CpG binding domain protein 3-like 5 |
chr4_-_34041504 | 0.41 |
ENST00000512581.1
ENST00000505018.1 |
RP11-79E3.3
|
RP11-79E3.3 |
chr4_-_139163491 | 0.41 |
ENST00000280612.5
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
chr9_+_470288 | 0.41 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr15_-_31393910 | 0.41 |
ENST00000397795.2
ENST00000256552.6 ENST00000559179.1 |
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1 |
chr2_-_70780572 | 0.41 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
chr2_-_89327228 | 0.41 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr8_-_131399110 | 0.41 |
ENST00000521426.1
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
chr7_-_99277610 | 0.41 |
ENST00000343703.5
ENST00000222982.4 ENST00000439761.1 ENST00000339843.2 |
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5 |
chr13_-_99667960 | 0.41 |
ENST00000448493.2
|
DOCK9
|
dedicator of cytokinesis 9 |
chr19_-_7040190 | 0.40 |
ENST00000381394.4
|
MBD3L4
|
methyl-CpG binding domain protein 3-like 4 |
chr17_+_59489112 | 0.40 |
ENST00000335108.2
|
C17orf82
|
chromosome 17 open reading frame 82 |
chr17_+_39261584 | 0.40 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
chr18_+_61445007 | 0.40 |
ENST00000447428.1
ENST00000546027.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr17_+_79495397 | 0.40 |
ENST00000417245.2
ENST00000334850.7 |
FSCN2
|
fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) |
chr6_+_127898312 | 0.39 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
chr2_+_90273679 | 0.39 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr15_-_55562479 | 0.39 |
ENST00000564609.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chrX_+_70798261 | 0.38 |
ENST00000373696.3
|
ACRC
|
acidic repeat containing |
chr2_+_90211643 | 0.38 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr4_-_143226979 | 0.38 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr17_+_62223320 | 0.38 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
chr20_-_13971255 | 0.38 |
ENST00000284951.5
ENST00000378072.5 |
SEL1L2
|
sel-1 suppressor of lin-12-like 2 (C. elegans) |
chr10_-_71169031 | 0.38 |
ENST00000373307.1
|
TACR2
|
tachykinin receptor 2 |
chr11_-_13517565 | 0.38 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chrX_-_21676442 | 0.37 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
chr1_+_156254070 | 0.37 |
ENST00000405535.2
ENST00000456810.1 |
TMEM79
|
transmembrane protein 79 |
chr13_+_109248500 | 0.37 |
ENST00000356711.2
|
MYO16
|
myosin XVI |
chr9_-_21351377 | 0.37 |
ENST00000380210.1
|
IFNA6
|
interferon, alpha 6 |
chr15_+_58430567 | 0.37 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
chr1_-_185597619 | 0.37 |
ENST00000608417.1
ENST00000436955.1 |
GS1-204I12.1
|
GS1-204I12.1 |
chr12_+_15699286 | 0.36 |
ENST00000442921.2
ENST00000542557.1 ENST00000445537.2 ENST00000544244.1 |
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chrX_-_153599578 | 0.36 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr5_+_60933634 | 0.36 |
ENST00000505642.1
|
C5orf64
|
chromosome 5 open reading frame 64 |
chr20_+_60174827 | 0.36 |
ENST00000543233.1
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal) |
chr12_-_53171128 | 0.36 |
ENST00000332411.2
|
KRT76
|
keratin 76 |
chrX_-_106243451 | 0.36 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
chr8_-_7287870 | 0.36 |
ENST00000318124.3
|
DEFB103B
|
defensin, beta 103B |
chr10_+_18549645 | 0.36 |
ENST00000396576.2
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr12_-_95510743 | 0.36 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr2_+_182850551 | 0.36 |
ENST00000452904.1
ENST00000409137.3 ENST00000280295.3 |
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
chr3_-_98235962 | 0.36 |
ENST00000513873.1
|
CLDND1
|
claudin domain containing 1 |
chr5_-_139726181 | 0.36 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr9_-_21368075 | 0.35 |
ENST00000449498.1
|
IFNA13
|
interferon, alpha 13 |
chr11_+_28129795 | 0.35 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
chr11_-_2323089 | 0.35 |
ENST00000456145.2
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr2_+_191045656 | 0.35 |
ENST00000443551.2
|
C2orf88
|
chromosome 2 open reading frame 88 |
chr6_+_30029008 | 0.35 |
ENST00000332435.5
ENST00000376782.2 ENST00000359374.4 ENST00000376785.2 |
ZNRD1
|
zinc ribbon domain containing 1 |
chr19_+_15838834 | 0.35 |
ENST00000305899.3
|
OR10H2
|
olfactory receptor, family 10, subfamily H, member 2 |
chr3_+_130569429 | 0.34 |
ENST00000505330.1
ENST00000504381.1 ENST00000507488.2 ENST00000393221.4 |
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
chr10_-_36812323 | 0.34 |
ENST00000543053.1
|
NAMPTL
|
nicotinamide phosphoribosyltransferase-like |
chr1_+_87012753 | 0.34 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr3_+_100354442 | 0.34 |
ENST00000475887.1
|
GPR128
|
G protein-coupled receptor 128 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 2.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 1.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.5 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.2 | 0.8 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.2 | 0.7 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.2 | 0.7 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 1.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 1.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.7 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.4 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 0.4 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.7 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 1.3 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.1 | 0.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.3 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 0.5 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.4 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.3 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.1 | 0.1 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) |
0.1 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.4 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.1 | 0.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 1.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.3 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.3 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.1 | 0.5 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.1 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
0.1 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 1.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.2 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.1 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 10.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.9 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.1 | 1.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 1.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 1.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.8 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.0 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 1.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.0 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.0 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.3 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.0 | 0.4 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.2 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 4.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) bone regeneration(GO:1990523) |
0.0 | 0.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.5 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.5 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.1 | GO:1903781 | positive regulation of cardiac conduction(GO:1903781) |
0.0 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.0 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.3 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.1 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.0 | 0.4 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 1.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.0 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 1.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.1 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.0 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0044851 | anagen(GO:0042640) hair cycle phase(GO:0044851) positive regulation of hair follicle maturation(GO:0048818) regulation of hair follicle maturation(GO:0048819) regulation of anagen(GO:0051884) positive regulation of anagen(GO:0051885) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 0.1 | GO:0044793 | response to yeast(GO:0001878) negative regulation by host of viral process(GO:0044793) |
0.0 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.0 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 1.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 5.2 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:0060459 | subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.0 | 0.3 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.0 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.0 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
0.0 | 0.0 | GO:1902523 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.0 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0007356 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.7 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.0 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0051005 | negative regulation of phospholipase activity(GO:0010519) negative regulation of lipoprotein lipase activity(GO:0051005) phospholipid homeostasis(GO:0055091) |
0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.3 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0021942 | regulation of definitive erythrocyte differentiation(GO:0010724) radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.5 | GO:0042339 | keratan sulfate biosynthetic process(GO:0018146) keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.0 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.2 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.0 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.0 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.1 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 1.2 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.0 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.0 | 0.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.0 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.0 | GO:0097475 | motor neuron migration(GO:0097475) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.3 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 3.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 9.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 1.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 1.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.3 | GO:0090543 | ESCRT III complex(GO:0000815) Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 2.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.7 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.2 | 1.0 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 3.0 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 1.0 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.5 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.2 | 0.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.5 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.4 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 2.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.6 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.9 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 1.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.0 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.0 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 1.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 0.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.0 | 0.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.0 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.0 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 2.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.0 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 7.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine receptor activity(GO:0016495) C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 1.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 1.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 2.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 3.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 8.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 2.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 4.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 3.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |